# S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients

> **NCT01824459** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 576 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** Oxaliplatin
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT01824459
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 576 (ACTUAL)
- **Last updated:** 2019-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824459, "S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01824459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*